Search

Kristin Listner Phones & Addresses

  • Chalfont, PA
  • 1010 Zachs View Cir, Warrington, PA 18976 (215) 343-5205
  • 413 Feldspar Ct, Warrington, PA 18976
  • 3 Russell Ct, Hightstown, NJ 08520 (609) 371-7162 (732) 438-8397
  • East Windsor, NJ
  • 519 Southridge Woods Blvd, Monmouth Junction, NJ 08852 (732) 438-8397
  • Monmouth Jct, NJ
  • 53 Brookhill Ave, Edison, NJ 08817
  • Buck, PA

Work

Company: Merck 2016 Position: Associate principal scientist, global vaccines and biologics commercialization

Education

Degree: Masters School / High School: Rutgers University 1998 to 2001 Specialities: Biochemistry

Skills

Vaccines • Assay Development • Commercialization • Biotechnology • Cell Biology • Biochemistry • Molecular Biology • Risk Assessment • Viral Inactivation • Regulatory Requirements • Mammalian Cell Culture • Bacterial Cell Culture • Upstream Processing • Fermentation Process Development • Gmp • Glp • Technology Transfer • Hplc • Media Development • Pharmaceutical Industry

Industries

Pharmaceuticals

Resumes

Resumes

Kristin Listner Photo 1

Associate Principal Scientist, Global Vaccines And Biologics Commercialization

View page
Location:
Collegeville, PA
Industry:
Pharmaceuticals
Work:
Merck
Associate Principal Scientist, Global Vaccines and Biologics Commercialization

Merck 2010 - 2016
Senior Scientist, Global Vaccines and Biologics Commercialization

Merck 2004 - 2009
Research Biochemist, Bioprocess Research and Development

Merck 2001 - 2004
Staff Microbiologist, Bioprocess Research and Development
Education:
Rutgers University 1998 - 2001
Masters, Biochemistry
Rutgers University 1994 - 1998
Bachelors, Bachelor of Arts, Molecular Biology, Biochemistry
Skills:
Vaccines
Assay Development
Commercialization
Biotechnology
Cell Biology
Biochemistry
Molecular Biology
Risk Assessment
Viral Inactivation
Regulatory Requirements
Mammalian Cell Culture
Bacterial Cell Culture
Upstream Processing
Fermentation Process Development
Gmp
Glp
Technology Transfer
Hplc
Media Development
Pharmaceutical Industry

Publications

Us Patents

Process For Large Scale Production Of Plasmid Dna By Fermentation

View page
US Patent:
8603798, Dec 10, 2013
Filed:
Jul 25, 2011
Appl. No.:
13/190137
Inventors:
Michel Chartrain - Westfield NJ, US
Laura Kizer Bentley - Monmouth NJ, US
Barbara Ann Krulewicz - Bloomfield NJ, US
Kristin M. Listner - East Windsor NJ, US
Wen-jun Sun - Edison NJ, US
Chanyong Brian Lee - Thousand Oaks CA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C12N 1/20
C12N 15/63
US Classification:
43525233, 4353201
Abstract:
The present invention relates generally to a method for increasing the yield of plasmid DNA production. The method includes the steps of selecting a highly productive clonal subtype of a strain of , including but not limited to the DH5 strain, harboring a DNA plasmid and cultivating said clonal subtype with fed-batch fermentation in a chemically-defined medium. The plasmid DNA production process described herein can generate record quantities of plasmid DNA when said highly productive clonal subtypes are cultivated on an industrial scale. The disclosed method can be used for the production of pharmaceutical grade DNA for use in polynucleotide vaccination and gene therapy treatment regimens.

Process For Large Scale Production Of Plasmid Dna By E.coli Fermentation

View page
US Patent:
20080274452, Nov 6, 2008
Filed:
Jan 31, 2005
Appl. No.:
10/588295
Inventors:
Michel Chartrain - Westfield NJ, US
Laura Kizer Bentley - Monmouth NJ, US
Barbara Ann Krulewicz - Bloomfield NJ, US
Kristin M. Listner - East Windsor NJ, US
Wen-jun Sun - Edison NJ, US
Chanyong Brian Lee - Thousand Oaks CA, US
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435 6, 435 911
Abstract:
The present invention relates generally to a method for increasing the yield of plasmid DNA production. The method includes the steps of selecting a highly productive clonal subtype of a strain of , including but not limited to the DH5 strain, harboring a DNA plasmid and cultivating said clonal subtype with fed-batch fermentation in a chemically-defined medium. The plasmid DNA production process described herein can generate record quantities of plasmid DNA when said highly productive clonal subtypes are cultivated on an industrial scale. The disclosed method can be used for the production of pharmaceutical grade DNA for use in polynucleotide vaccination and gene therapy treatment regimens.
Kristin M Listner from Chalfont, PA, age ~49 Get Report